Corvus Pharmaceuticals Down Over 10%, on Pace for Largest Percent Decrease Since March 2025 -- Data Talk

Dow Jones00:34

Corvus Pharmaceuticals, Inc. (CRVS) is currently at $22.53, down $2.57 or 10.24%

--On pace for largest percent decrease since March 26, 2025, when it fell 14.76%

--Currently down two consecutive days; down 11.72% over this period

--Worst two day stretch since the two days ending Jan. 5, 2026, when it fell 11.82%

--Up 192.6% month-to-date; on pace for best month on record (Based on available data back to March 23, 2016)

--Up 192.6% year-to-date

--Down 11.72% from its all-time closing high of $25.52 on Jan. 22, 2026

--Up 344.38% from 52 weeks ago (Jan. 27, 2025), when it closed at $5.07

--Down 11.72% from its 52-week closing high of $25.52 on Jan. 22, 2026

--Up 698.94% from its 52-week closing low of $2.82 on April 8, 2025

--Traded as low as $21.82

--Down 13.07% at today's intraday low; largest intraday percent decrease since May 12, 2025, when it fell as much as 13.32%

All data as of 11:32:34 AM ET

Source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

January 26, 2026 11:34 ET (16:34 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment